December 6 (SeeNews) - Bulgarian drug trader Sopharma Trading [BUL:SO5] said on Thursday that its majority owner - drug maker Sopharma [BUL:3JR], has increased its stake in the company by acquiring 1,000 shares in two deals priced at 6.95 levs ($4.03/3.55 euro) per share.
Sopharma acquired the shares on the floor of the Bulgarian Stock Exchange on Wednesday, Sopharma Trading said in a bourse filing.
You can subscribe to our M&A newsletter here
The 1,000 shares are equal to a 0.003% stake in Sopharma Trading, according to bourse data.
Sopharma has 10 production facilities and a portfolio of over 210 products.
(1 euro = 1.95583 levs)